ing for some sites within an area of ICS is hardly modified by doses clearly changing pressing for other sites (Leibman & Segal, 1976) . These individual differences may be due to slight differences in exact focus of stimu· lation, to broader individual differences in reactivity of a subject to opioids, or to an interaction between these two classes of variables. As with other focuses of ICS, responsiveness to opioids differed widely with respect to pressing for amygdaloid ICS.
MEmOD

Subjects
Under pentobarbital anesthesia, four male albino rats were each fixed with a chronically indwelling bipolar electrode (Plastic Products). The strands of the electrodes were insulated except at the cross section of the tip and separated from each other only by the insulation. The rats weighed 200-250 g at the time of the surgery.
The stimulating tip of the electrodes was aimed for the cen· tral and medial amygdaloid nuclei (Koning & Klippel, 1963) . Subsequent analysis showed that the electrode tips were, indeed, within the region of these nuclei. Following surgeries, each rat was maintained in an individual cage, with food and water always available.
Apparatus
A clear plastic box (30 x 24 x 35 cm) equipped with a lever was used; it was housed in a lighted, sound~ttenuating box. The depression of the lever delivered a .25-sec train of 60-Hz sine waves at various intensities, but always less than 30 microA. The number of presses was recorded automatically at the end of each 5-min period, during I-h daily testing sessions.
Procedure
After at least 5 days for recovery from the surgery, the subjects were shaped to press for ICS, and an intensity was determined to be used throughout the remaining tests. Since ICS of the amygdala frequently engenders seizures, relatively low intensities of ICS were selected. Nevertheless, seizures occurred, and when they occurred, testing was suspended until the rats returned to pressing.
The subjects were trained until the response rates stabilized. Stabilization was achieved when the average of 3 consecutive days did not differ more than 10% from responding on the next day. After stabilization and across the next 6 days, the subjects were injected 3 h before the testing session with morphine sulphate (10 mg/kg, ip). Across the following 5 days, the subjects received saline solution in doses of the same volume (1 ml/kg, ip). The subjects were then injected with naloxone (10 mg/kg, ip) 15 min before testing on 5 consecutive days. Finally, across the next 5 days, all the subjects received saline injections (1 ml/kg). At the end of behavioral testing, the subjects were sacrificed with an overdose of pentobarbital and perfused flIst with saline and then with 10% formaldehyde. Subsequently, the brains were taken and sectioned. As an aid in determining the position of electrode tips, sections were treated as photographic negatives, and enlarged (10x) photographs were made.
RESULTS AND DISCUSSION
Pressing rates did not reliably differ across days of baseline and days when placebo injections were given. We took, therefore, the mean of all pressing across baseline and placebo tests to represent press rates when subjects were not under the influence of opioids. Pressing was modified similarly across the 5 min of each testing. Consequently, only mean pressing rates across a daily session are reported here.
Under baseline and placebo and across all subjects and 5-min tests, the mean presses per 5 min was 198. Under morphine, the mean presses per 5 min was 308. Under naloxone, the mean presses per 5 min was 58.
All subjects' mean response rates were higher under morphine than under placebo, but subjects differed considerably in the extent of the increase, with one subject showing an 11 % increase and another showing a 59% increase. A t test for correlated measures of the scores from placebo and morphine tests yielded t(3) = 2.45 (p < .05, one-tailed test).
All subjects' mean response rates were lower under naloxone, with one subject showing a 52% decrease and another showing a 90% decrease . A t test comparing scores from placebo and naloxone tests yielded t(3) = 3.40 (p < .02, one-tailed test). A t test comparing scores from naloxone and morphine tests yield a t(3) = 3.81 (p < .02, one-tailed test).
The subjects' press rates were low compared with pressing for ICS of the lateral hypothalamus, a result confirming the data presented by Wurtz and Olds (1963) using rats and by Porter, Conrad, and Brady (1959) using monkeys. The subjects frequently had seizures (when seizures occurred, recording of pressing was suspended). Morphine injections seemed to induce a slight increase in number of seizures, but naloxone had no discernible effect. We may have missed, however, instances of brief seizures. In the time period from injection of morphine to the time of testing, the subjects were often observed to be eating or gnawing.
The magnitude of the change under the influence of the drugs is greater than that seen with other sites of ICS (Stapleton et al., 1979) . This may be due to the low rates of baseline or to the fact that the amygdaloid area is particularly reactive to opioids. Perhaps measures of threshold change would allow some conclusions with respect to whether the amygdaloid area is particularly reactive to these drugs. Although it is clear that, within a region in which electrodes are placed, there are individual differences in reactivity to morphine and naloxone, mean press rates with every region tested are increased by appropriate doses of morphine and decreased by doses of naloxone. Such a result leads to the suggestion that there is a component to the "intracranial reinforcement system" that is endorphinergic. These data, therefore, add to a growing body of evidence (e.g., Esposito & Kornetsky, 1978; Rossi & Reid, 1976; Stapleton et al., 1979) supporting the proposition that there is concordance between the capacity of opioids to be reinforcing (addicting?) and the neurophysiology of intracranial reward.
